Lose weight by eating less salt! - Go on! - Try it! - You will feel so much better!
See my website
Wilde About Steroids

Read my Mensa article on Obesity and the Salt Connection

Read my Mensa article on Cruelty, Negligence and the Abuse of Power in the NHS: Fighting the System

Read about the cruel treatment I suffered at the Sheffield Dental Hospital: Long In The Toothache

You can contact me by email from my website. The site does not sell anything and has no banners, sponsors or adverts - just helpful information about how salt can cause obesity.

Monday, 21 May 2007

Coming soon: the shopping channel run by drug firms - Guardian

What a truly horrifying prospect! - Drug companies cannot be trusted to tell the truth...)o: And pharmaceutical drugs cause very great harm because of dangerous side-effects and because of reckless prescribing or wrong administration.

See http://aboutsalt.blogspot.com/search/label/Pharmaceutical%20industry and http://aboutsalt.blogspot.com/search/label/Pharmaceutical%20companies and http://aboutsalt.blogspot.com/2007/05/nhs-hospital-patients-dying-as-10000.html and http://aboutsalt.blogspot.com/search/label/Steroid%20Victims

Extract from the Guardian article:

"Four of the world's biggest pharmaceutical companies are proposing to launch a television station to tell the public about their drugs, amid strenuous lobbying across Europe by the industry for an end to restrictions aimed at protecting patients. Pharma TV would be a dedicated interactive digital channel funded by the industry with health news and features but, at its heart, would be detailed information from drug companies about their medicines.

A 10-minute pilot DVD, seen by the Guardian, featured a white-coated doctor discussing breast cancer and a woman patient who reassured viewers that "there are many new treatments available". Under the proposals, viewers could use their remote control to click on treatment options and read what manufacturers have to say about the latest branded breast cancer drugs.

Four companies, Johnson and Johnson, Pfizer, Novartis and Procter and Gamble, are behind the pilot, which they are offering to the European commission as a way to give patients more information. The commission is consulting on potential changes to the regulations that ban all direct-to-consumer advertising of medicinal drugs.

The industry has been lobbying in Europe to be allowed direct access to patients. It argues that lifting restrictions would help its competitiveness and has hinted that companies may relocate to the US, where they can advertise to patients who then demand drugs from their doctors. Profits have soared there as a result.

The proposed change in the rules is being led within the commission by its trade arm, DG Enterprise, and not health, DG Sanco. It is backed by a number of influential patient groups that are themselves heavily funded by drug companies. But consumer organisations are opposed, warning that the companies will play down risk, and that their real interest lies in boosting profits.

The International Society of Drug Bulletins (ISDB) - consumer publications which analyse the benefits of drugs and draw comparisons between them - warns that the industry is not a reliable source of trustworthy information.

The US and New Zealand allow drug companies to advertise to the public; the ISDB says in both these countries this has been shown to be detrimental to health.

"Pharmaceutical companies' messages are focused on relatively few top sellers, exaggerating effects and concealing risks, confusing patients and putting pressure on doctors to prescribe drugs they would not use otherwise," it says. "Lack of comparative information in advertising means people cannot choose among several options." Johnson & Johnson presented the companies' proposals to a meeting in Brussels of the Centre for Health, Ethics and Society, a thinktank which describes itself as "developed in partnership with Johnson & Johnson". The audience comprised members of the commission, patient groups and others."

No comments:

Post a Comment